Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Lowenstein

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Progress in Brain Research|February 5, 1999
Gene therapy for inherited neurological disorders: towards therapeutic intervention in the Lesch-Nyhan syndromeP R Lowenstein, T D Southgate, J R Smith-Arica, et al.
Journal of Molecular Endocrinology|December 1, 1990
The use of inclusion bodies, isolated from Escherichia coli expressing corticotrophin-releasing hormone precursor, to raise specific antibodies against the neuropeptide moietyM G Castro, P R Lowenstein, P W Saphier, et al.
Human Molecular Genetics|April 1, 1996
Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brainJ D Wood, J C MacMillan, P S Harper, et al.
Neurochemistry International|November 1, 1994
Evidence for cholinergic vagal afferents and vagal presynaptic M1 receptors in the ferretD J Reynolds, P R Lowenstein, J M Moorman, et al.
Journal of Neuroendocrinology|April 1, 1995
Expression of biologically active procorticotrophin-releasing hormone (proCRH) in stably transfected CHO-K1 cells: characterization of nuclear proCRHE Morrison, P Tomasec, E A Linton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivoJ Yang, N S R Sanderson, K Wawrowsky, et al.
Neuroendocrinology|February 5, 2000
Generation of a recombinant herpes simplex virus type 1 expressing the rat corticotropin- releasing hormone precursor: endoproteolytic processing, intracellular targeting and biological activityP Tomasec, C M Preston, E A Linton, et al.
Biochemical Society Transactions|November 1, 1995
Characterising the Huntington's disease gene productJ Wood, J C MacMillan, P Thomas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 1999
Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brainT Cartmell, T Southgate, G S Rees, et al.
Molecular and Cellular Endocrinology|August 15, 1998
Use of recombinant herpes simplex virus type 1 vectors for gene transfer into tumour and normal anterior pituitary cellsR G Goya, J Rowe, Y E Sosa, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Progress in Brain Research|February 5, 1999
Gene therapy for inherited neurological disorders: towards therapeutic intervention in the Lesch-Nyhan syndromeP R Lowenstein, T D Southgate, J R Smith-Arica, et al.
Journal of Molecular Endocrinology|December 1, 1990
The use of inclusion bodies, isolated from Escherichia coli expressing corticotrophin-releasing hormone precursor, to raise specific antibodies against the neuropeptide moietyM G Castro, P R Lowenstein, P W Saphier, et al.
Human Molecular Genetics|April 1, 1996
Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brainJ D Wood, J C MacMillan, P S Harper, et al.
Neurochemistry International|November 1, 1994
Evidence for cholinergic vagal afferents and vagal presynaptic M1 receptors in the ferretD J Reynolds, P R Lowenstein, J M Moorman, et al.
Journal of Neuroendocrinology|April 1, 1995
Expression of biologically active procorticotrophin-releasing hormone (proCRH) in stably transfected CHO-K1 cells: characterization of nuclear proCRHE Morrison, P Tomasec, E A Linton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivoJ Yang, N S R Sanderson, K Wawrowsky, et al.
Neuroendocrinology|February 5, 2000
Generation of a recombinant herpes simplex virus type 1 expressing the rat corticotropin- releasing hormone precursor: endoproteolytic processing, intracellular targeting and biological activityP Tomasec, C M Preston, E A Linton, et al.
Biochemical Society Transactions|November 1, 1995
Characterising the Huntington's disease gene productJ Wood, J C MacMillan, P Thomas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 1999
Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brainT Cartmell, T Southgate, G S Rees, et al.
Molecular and Cellular Endocrinology|August 15, 1998
Use of recombinant herpes simplex virus type 1 vectors for gene transfer into tumour and normal anterior pituitary cellsR G Goya, J Rowe, Y E Sosa, et al.
Pageof 13